Micropharma Limited: Clinical Trials

5 trials sponsored by Micropharma Limited, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 11Completed 1

Follow Micropharma Limited: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of L. Reuteri NCIMB 30242 on Plasma Bile Acid Profile
Delayed release capsule, L. reuteri NCIMB 30242, escalated dose, Standard vegetarian capsule, L. reuteri NCIMB 30242, escalated dose - Hypercholesterolemia
Phase 2CompletedMicropharma Limited102013-11-012014-08-15
Efficacy of a One-a-Day L. Reuteri NCIMB 30242 Probiotic Supplement Capsule
One-a-Day L. reuteri NCIMB 30242 supplement capsule, One-a-Day placebo capsule - Hypercholesterolemia
Phase 2CompletedMicropharma Limited1502012-08-012014-06-26
Efficacy of Cardioviva™ Probiotic Supplement Capsule Formulation
Cardioviva™ supplement capsule, Placebo capsule - Hypercholesterolemia
Phase 2CompletedMicropharma Limited1312011-05-012011-11-02
Efficacy of Cardioviva™ Probiotic Yogurt Formulation
Cardioviva™ yogurt, Placebo yogurt - Hypercholesterolemia
Phase 2CompletedMicropharma Limited1502008-09-012012-07-02
Efficacy of Two Yogurt Formulations in Healthy Humans
L. Amylovorus, L. Fermentum - Healthy
Phase 1CompletedUniversity of Manitoba302007-09-012011-08-04

Conditions studied

Hypercholesterolemia (4)

Countries

Canada (1)  ·  Czechia (1)

Top investigators

Mitchell L Jones, MD, MEng (1)

Results publications

PMID 22561556, PMID 23148122, PMID 24074303